Indonesia Seeks CEPI's Support for Tuberculosis Vaccine Development

Tempo
15 Feb

TEMPO.CO, Jakarta - Deputy Foreign Minister Arrmanatha Christiawan Nasir reaffirmed Indonesia’s commitment to strengthening the global health architecture in anticipation of future pandemics. This statement was made during his meeting with Coalition for Epidemic Preparedness Innovations (CEPI) representatives at the Ministry of Foreign Affairs in Jakarta on Wednesday, February 12

CEPI’s visit aims to discuss enhancing their collaboration with Indonesia, focusing on promoting national vaccine production independence while ensuring equitable access to health products for all nations worldwide.

“Indonesia’s collaboration with CEPI is crucial for advancing the vaccine industry, strengthening local manufacturing capacity, and building a pandemic response ecosystem in Indonesia,” Arrmanatha stated, as quoted from the official Kemlu website. He highlighted that this initiative aligns with the priorities set by President Prabowo Subianto.

Strengthening Partnerships and Vaccine Production Capacity

The CEPI delegation was led by Chair of the CEPI Board, Jane Halton, and CEO Richard Hatchett. "The role of the Ministry of Foreign Affairs is critical in advancing Indonesia's partnership with CEPI. Indonesia has been one of CEPI’s strategic partners since 2020," Jane Halton emphasized.

CEPI also supports Indonesia’s vaccine production capacity, including collaboration with PT Bio Farma, one of Indonesia’s prominent vaccine manufacturers.

Arrmanatha expressed gratitude for CEPI’s support and emphasized the need for further cooperation. “I hope CEPI can also support the development of a tuberculosis vaccine in Indonesia. Combating tuberculosis is a priority for the Indonesian government, and it aligns with CEPI’s program,” he added.

About CEPI

CEPI is a public-private partnership founded in Davos, Switzerland in 2017 by Norway, India, the Bill and Melinda Gates Foundation, Wellcome Trust, and the World Economic Forum. The organization focuses on developing health products to prepare for future health risks.

Editor’s Choice: Free Health Check Program: List of Available Screenings

Click here to get the latest news updates from Tempo on Google News

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10